BTLA Peptide
| Code | Size | Price |
|---|
| PSI-7473P-0.05mg | 0.05mg | £166.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Target Species: Human
Documents
Further Information
Additional Names:
BTLA1, CD272, B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein
Application Note:
The peptide is used for blocking the activity of BTLA antibody (catalog number 7473). It usually blocks the antibody activity completely by incubating the peptide with equal volume of antibody for 30 min at 37˚C.
Background References:
- Carreno BM and Collins M. BTLA: a new inhibitory receptor with a B7-like ligand. Trends Immunol. 2003; 24:524-7.
Buffer:
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Concentration:
200 ug/mL
NCBI Gene ID #:
151888
NCBI Official Name:
B and T lymphocyte associated
NCBI Official Symbol:
BTLA
NCBI Organism:
homo sapiens
Peptide aa Location:
17 amino acids near the center of human BTLA.
Physical State:
Liquid
Protein Accession #:
NP_861445
Protein GI Number:
145580621
Swissprot #:
Q7Z6A9